Timing matters in combination therapy.
- Published in:
- Science Signaling, 2020, v. 13, n. 622, p. N.PAG, doi. 10.1126/scisignal.abb5803
- By:
- Publication type:
- Article
Works matching IS 19450877 AND DT 2020 AND VI 13 AND IP 622
Results: 3
1
2
Mortalin (HSPA9) facilitates BRAF-mutant tumor cell survival by suppressing ANT3-mediated mitochondrial membrane permeability.
- Published in:
- Science Signaling, 2020, v. 13, n. 622, p. 1, doi. 10.1126/scisignal.aay1478
- By:
- Publication type:
- Article
3
Structure-based mechanism of preferential complex formation by apoptosis signal–regulating kinases.
- Published in:
- Science Signaling, 2020, v. 13, n. 622, p. 1, doi. 10.1126/scisignal.aay6318
- By:
- Publication type:
- Article